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Quick guide
Figure 1. Fluorescent protein fusions in Candida albicans. 
Useful fluorescent markers for tracking subcellular structures in C. albicans include: DAPI 
(DNA); Nop1-GFP (green fluorescent protein, localizing to the nucleolus); Hhf1-GFP (chromatin); 
Tub2-GFP (microtubules, green); and Tub4-mCherry fluorescent protein (spindle pole bodies, 
red). Micrographs courtesy of Shelly Applen and Benjamin Harrison.What is Candida albicans? Candida 
albicans is the best studied and 
most prevalent of the human fungal 
pathogens. Candida species are 
fungi that grow as yeasts and that are 
‘imperfect’, meaning they apparently 
lack a complete sexual cycle; yet 
C. albicans and several related 
species clearly have the potential 
to engage in ‘parasex’ (described 
below). C. albicans, thought to be 
an obligate diploid, can form true 
filamentous hyphae in addition to the 
budding yeast and pseudohyphal 
(elongated yeast) cells seen in other 
Candida species and in the model 
yeast Saccharomyces cerevisiae. 
What kinds of conditions cause 
C. albicans to become a pathogen? 
C. albicans is an opportunistic 
pathogen that resides as a harmless 
commensal in the gut, genito-
urinary tract and skin. It becomes 
an opportunistic pathogen under a 
number of different host conditions, 
usually involving reduced immune 
competence or an imbalance of 
the competing bacterial microflora. 
Mucosal infections, such as oral 
thrush or vaginitis, are usually not 
life-threatening, but they can be 
the sentinel symptom of immune 
suppression, for example in patients 
infected with HIV. Much more serious 
are blood stream candidal infections, 
which are associated with high 
mortality rates. The limited arsenal 
of antifungal drugs and the ability 
of drug resistance to arise through 
multiple mechanisms, including the 
natural drug resistance of biofilms, 
contribute to the recalcitrance of 
candidal infections and their position 
as the third or fourth most common 
cause of nosocomial (hospital-
acquired) infections. 
What processes are most important 
for pathogenicity? The genetic and 
physiological changes accompanying 
the shift of C. albicans from a 
commensal to a pathogenic lifestyle 
are being investigated using clinical 
isolates, by animal studies (primarily with mice using oral and bloodstream 
infection models), and by tissue 
culture and other in vitro approaches 
(Figure 1). Next generation 
sequencing is expected to provide 
many insights into the genetic, 
genomic and transcriptomic changes 
involved, while studies of metabolism 
and protein composition should 
provide a clearer view of physiological
changes that occur during this 
transition. 
Another approach is to focus 
on gene families that have been 
amplified considerably in C. albicans 
relative to other, less pathogenic, 
Candida species. These include 
agglutinin-like sequence (ALS) genes, 
the products of which promote 
adhesion between individual cells, 
adhesion between cells and host 
tissues, and invasion of host tissue by 
stimulating endocytosis. Indeed, Als3 
is being developed as an anti-fungal 
vaccine. Other amplified gene families 
encode secreted aspartyl proteases 
and lipases that can promote tissue 
invasion and ferric reductases, 
which facilitate iron-acquisition in 
the iron-limiting host environment. 
An intriguing gene family that also 
has been amplified considerably 
relative to less pathogenic Candida 
species is the telomere-associated 
TLO gene family, members of which 
appear to encode variant copies of 
a single component of the mediator 
complex, a major regulator of general 
transcription. 
What is a parasexual cycle? While 
conventional meiosis has not been 
described, C. albicans does have 
two mating types (a and alpha) and 
orthologs of many genes involved 
in meiosis in S. cerevisiae and other 
eukaryotes. Most clinical isolates are  
diploid or near diploid, and a small 
proportion of them are homozygous 
for the mating-type locus, suggesting 
that they have the potential to mate. A 
physiogical/epigenetic switch from the 
standard ‘white’ phase to an ‘opaque’ 
state is a prerequisite for mating 
between diploids to form tetraploids 
(Figure 2). Under some stress 
conditions these tetraploids return to 
a near-diploid state, albeit with many 
of them carrying at least one extra 
(aneuploid) chromosome and some of 
them having undergone recombination 
events that require Spo11, a protein 
necessary for meiotic recombination 
in organisms with bona fide meiosis. 
This alteration of generations 
from diploids to tetraploids and 
then back to near-diploids without 
conventional meiosis is termed the 
‘parasexual cycle’. The aneuploid 
progeny generally carry from one to 
three aneuploid chromosomes. The 
ability to tolerate aneuploidy and 
other chromosomal rearrangements 
apparently provides C. albicans with 
a non-Mendelian type of genetic 
diversity that likely facilitates its 
adaptation to the broad range of harsh 
environments within the host. 
What is morphological switching? 
C. albicans grows with several 
different morphologies: by budding 
to form oval yeast and elongated 
pseudohyphae; or with exclusively 
polarized growth to form uninucleate 
true hyphae, which resemble the 
true hyphae of filamentous fungi. 
Phenotypic switching of mating-type 
homozygous oval white cells to the 
oblong ‘opaque’ form involves a 
switch to mating competence as well 
as a change in cell-wall properties 
thought to make the cells more 
permeable to mating pheromones. 
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Figure 2. Phenotypic switching in Candida albicans.
Growth of C. albicans cells on phloxine plates detects colonies of cells that are either white 
(white colonies) or opaque (pink colonies) (left panel). A subset of cells in a mostly white colony 
switched to the opaque state, forming a sector in the colony (right panel). Photos courtesy of 
Meleah Hickman.Another morphological switch 
leads to formation of enlarged, round 
‘chlamydospores’ at the end of an 
elongated stalk cell in response 
to specific signals and nutritional 
conditions. 
All of the different morphological 
states are associated with different 
gene expression patterns and specific 
changes in cell cycle progression 
patterns: for example, yeast, 
pseudohyphae, and true hyphae 
exhibit different degrees of integration 
between the cell growth aspect of cell 
cycle progression and the nuclear and 
spindle cycles. 
What are biofilms? Biofilms are 
multicellular communities growing on 
the surface of tissues or indwelling 
medical devices, such as catheters 
or dental prostheses. Cells in biofilms 
exhibit drug resistance relative to 
genetically identical planktonic 
cells (unattached cells growing in 
a liquid culture), which is due to 
heterogeneity of the morphology 
(yeast, pseudohyphae, hyphae, white 
and opaque cells) and of the metabolic 
state (quiescent and actively growing, 
level of pheromone responsiveness) 
in the population. In addition, the 
extracellular matrix material that is 
characteristic of biofilms can sequester 
some antifungal drugs, reducing 
their effective concentration. Biofilm 
communities also engage in signaling 
processes, incuding quorum sensing, 
a response to cell density that affects 
growth, morphogenesis and that likely 
promotes survival in the host. 
What causes antifungal drug 
resistance? The identification of 
drug targets and development 
of effective antifungal drugs is 
complicated by the similarity 
between the eukaryotic fungi and 
their hosts. There are only three 
major classes of antifungal drugs 
used to treat candidal infections. 
Resistance to the most widely used 
of these, the azoles, is increasing, 
especially in patients, such as those 
with HIV, who are given azoles 
prophylactically. The echinocandins 
were introduced in the last decade 
to target cell-wall biosynthesis and 
reports of echinocandin resistance 
and tolerance are becoming more 
frequent. 
Drug resistance arises within 
existing commensal strains, and 
not via the horizontal transfer mechanisms typically seen in 
prokaryotic pathogens. Rather, 
antifungal drug resistance appears 
through several independent, and 
potentially synergistic mechanisms, 
including: altered activity or regulation 
of drug efflux transporters; new point 
mutations; homozygosis of existing 
mutations or increased copy number 
of genes encoding the drug targets 
(such as ERG11, which encodes 
lanosterol 140alpha-demethylase, the 
target of azole drugs involved in sterol 
biosynthesis); alterations in regulatory 
factors that regulate the drug efflux 
pumps or targeted biochemical 
pathways (such as the ergosterol 
biosynthesis pathway). 
Some chromosomal 
rearrangements or amplifications 
have further effects on one or more of 
these mechanisms, thereby causing 
increased drug resistance. While 
aneuploidy is found in half of all 
drug-resistant isolates, the increased 
copy number of specific genes with 
canonical roles in drug resistance 
is responsible for at least some of 
the resistance seen in lab as well as 
clinical isolates, suggesting that the 
number of copies of specific genes 
or combinations of genes provides 
a selective advantage to some 
aneuploid isolates. 
What molecular tools are available 
for working with C. albicans and 
other Candida species? In general, 
genetic studies of C. albicans have 
been slowed by the lack of a meiotic 
cycle, a haploid phase and stable 
autonomously maintained plasmids 
(most integrate very rapidly). Thus, 
most work has exploited genomics 
approaches that received a great 
boost with the 2004 publication of the first C. albicans genome sequence 
and subsequent assembly of this 
sequence into a chromosome-based 
genome map. The publication of 
sequences for other Candida species, 
in 2009, greatly facilitates work in 
these CUG clade members as well. 
Because of their native levels of 
drug resistance and/or their ability 
to become resistant rapidly, species 
such as Candida krusei and Candida 
glabrata are becoming more prevalent 
in the clinic.
Genomic studies are facilitated by 
several genome websites, including 
the Candida Genome Database, 
the Candida DB, the Broad Fungal 
Genome initiative, the Sanger 
institute, and Genolevures (see 
URL links below). Several useful 
collections of deletion strains, 
conditional repression strains and a 
soon-to-be available overexpression 
strain collection permit screening of 
a substantial proportion of known 
genes for their roles in specific 
phenotypes.
How similar is C. albicans to 
the model yeast S. cerevisiae? 
C. albicans and S. cerevisiae 
are thought to have diverged 
approximately 140–850 million years 
ago. While the two yeasts resemble 
each other in many ways, C. albicans 
is not simply a baker’s yeast that 
lost meiosis and acquired virulence 
traits. C. albicans survives in a much 
broader range of ecological niches 
and undergoes a parasexual cycle 
involving a physiological switch to 
‘opaque’ cells that is involved in 
regulating virulence in a broad range 
of pathogenic fungi and is not seen 
in S. cerevisiae. In addition, since 
their last common ancestor, the two 
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therapeutics to target protein-folding 
pathways and UPR signaling to resolve 
protein misfolding in disease states 
in a manner that was not previously 
conceivable.
IRE1–XBP1 
The most conserved branch of the 
UPR is mediated by IRE1, a type I 
transmembrane protein with both a 
serine/threonine kinase domain and 
an endoribonuclease (RNase) domain 
in its cytosolic portion. In yeast, Ire1p 
is the only identified ER stress sensor. 
There are two IRE1 homologues 
in mammals: IRE1a is expressed 
ubiquitously, whereas IRE1b expression 
is mostly restricted to the intestinal 
epithelium. 
Two models have been proposed 
for the activation of IRE1/Ire1p. The 
first is a competition-binding model 
that posits unfolded and/or misfolded 
proteins in the ER lumen compete with 
Ire1p for binding to the chaperone BiP. 
Ire1p binding to BiP inhibits signaling, 
whereas Ire1p released from BiP 
forms homodimers and oligomers that 
promote trans-autophosphorylation 
and RNase activation. Alternatively, 
since the crystal structure of the 
yeast Ire1p luminal domain revealed 
the presence of a peptide-binding 
groove similar to that of major 
histocompatibility class I molecules, it 
was proposed that unfolded/misfolded 
proteins directly bind to the amino-
terminal luminal domain of Ire1p to 
induce dimerization. A recent study 
showed that unfolded proteins and 
hydrophobic peptides bind to the 
core luminal domain of Ire1p, which 
then undergoes dimerization in vitro. 
In contrast, the peptide-binding cleft 
in the crystal structure of the luminal 
domain of human IRE1a is not solvent 
accessible and the luminal domain 
does not interact with unfolded 
proteins in vitro. A mutant form of 
IRE1a that cannot bind to BiP is 
able to spontaneously dimerize and 
activate kinase/RNase activities in the 
absence of ER stress, suggesting that 
mammalian IRE1a may be released 
from BiP but may not require peptide 
binding for activation. 
The luminal domain of IRE1a forms 
homodimers in the plane of the ER 
membrane, juxtaposing the kinase 
domains for trans-autophosphorylation 
to stimulate the kinase and RNase 
activities. These activities initiate the 
removal of a 26 base intron from the 
mRNA encoding X-box-binding protein 
Unfolded protein 
response
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In eukaryotic cells, the endoplasmic 
reticulum (ER) is a membrane-enclosed 
interconnected organelle responsible 
for the synthesis, folding, modification, 
and quality control of numerous 
secretory and membrane proteins. 
The processes of protein folding and 
maturation are highly assisted and 
scrutinized but are also sensitive to 
changes in ER homeostasis, such 
as Ca2+ depletion, oxidative stress, 
hypoxia, energy deprivation, metabolic 
stimulation, altered glycosylation, 
activation of inflammation, as well as 
increases in protein synthesis or the 
expression of misfolded proteins or 
unassembled protein subunits. Only 
properly folded proteins can traffic 
to the Golgi apparatus, whereas 
those that misfold are directed to 
ER-associated degradation (ERAD) 
or to autophagy. The accumulation 
of unfolded/misfolded proteins in 
the ER activates signaling events 
to orchestrate adaptive cellular 
responses. This unfolded protein 
response (UPR) increases the ER 
protein-folding capacity, reduces global 
protein synthesis, and enhances ERAD 
of misfolded proteins. 
In mammals, the UPR is signaled 
through three ER transmembrane 
protein sensors (Figure 1): inositol-
requiring kinase 1 (IRE1), pancreatic 
ER eIF2a kinase (PERK), and activating 
transcription factor 6 (ATF6). The 
luminal domain of each sensor 
responds to the level of unfolded/
misfolded protein in the ER. If the cell 
cannot resolve the protein-folding 
defect, cell-death signaling pathways 
are activated. As our understanding 
of ER protein-folding pathways and 
the mechanisms of UPR signaling of 
adaptive and apoptotic responses 
has grown, so has the significance 
of their impact on the etiology 
of multiple human pathologies, 
including metabolic syndrome, 
neurodegenerative disorders, 
inflammatory disease and cancer. With 
this armamentarium of knowledge, it 
is now possible for rational design of 
Primeryeasts have rewired many regulatory networks, such that processes as 
diverse as ribosomal protein gene 
regulation, galactose metabolism and 
mating-type switching, which appear 
to be very similar at the physiological 
level, are regulated by different 
transcription factors that bind to 
different regulatory sequences. 
Despite its evolutionary distance 
to S. cerevisiae being relatively short, 
C albicans, like other members of 
the ‘CUG’ clade, has a genetic code 
with a non-standard codon — CUG 
encodes serine rather than the 
conventional leucine — obviating the 
direct use of many genetic markers 
from heterologous organisms such as 
S. cerevisiae. This obstacle has been 
overcome by the development of 
codon-optimized markers, fluorescent 
proteins and other epitope tags, 
which can be inserted into the 
genome by several approaches 
all ultimately involving homology-
based recombination. These tools 
have led to many of the important 
advances in our understanding of the 
molecular mechanisms specifying 
mating, white-opaque switching, 
biofilm formation and other processes 
important for pathogenicity and 
virulence. There are clearly many 
more to come.
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